Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives. | Cells | 2023 | 36980246 | PubTator, text mining | PubMed |
| Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis. | Biomedicines | 2023 | 36979969 | PubTator, text mining | PubMed |
| MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. | Biomolecules | 2023 | 36979503 | PubTator, text mining | PubMed |
| The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity. | Front Physiol | 2023 | 36969584 | PubTator, text mining | PubMed |
| Anthracycline-induced cardiotoxicity - are we about to clear this hurdle? | Eur J Cancer | 2023 | 36966697 | PubTator, text mining | PubMed |
| Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA. | Nucleic Acids Res | 2023 | 36940725 | PubTator, text mining | PubMed |
| Downregulation of Hsp90 and the antimicrobial peptide Mtk suppresses poly(GR)-induced neurotoxicity in C9ORF72-ALS/FTD. | Neuron | 2023 | 36931278 | PubTator, text mining | PubMed |
| Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. | Cell Commun Signal | 2023 | 36918950 | PubTator, text mining | PubMed |
| Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer. | Mol Ther Nucleic Acids | 2023 | 36910711 | PubTator, text mining | PubMed |
| Increased Intracellular Free Zinc Has Pleiotropic Effects on Doxorubicin-Induced Cytotoxicity in hiPCS-CMs Cells. | Int J Mol Sci | 2023 | 36901950 | PubTator, text mining | PubMed |
| Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer. | Heliyon | 2023 | 36879965 | PubTator, text mining | PubMed |
| A noncanonical response to replication stress protects genome stability through ROS production, in an adaptive manner. | Cell Death Differ | 2023 | 36869180 | PubTator, text mining | PubMed |
| Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing. | Blood Adv | 2023 | 36848637 | PubTator, text mining | PubMed |
| Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A Review. | Biomedicines | 2023 | 36830926 | PubTator, text mining | PubMed |
| Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia. | Respir Res | 2023 | 36829233 | PubTator, text mining | PubMed |
| Epigenetic markers in the embryonal germ cell development and spermatogenesis. | Basic Clin Androl | 2023 | 36814207 | PubTator, text mining | PubMed |
| Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19. | Comput Biol Med | 2023 | 36805221 | PubTator, text mining | PubMed |
| Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action. | Redox Biol | 2023 | 36773545 | PubTator, text mining | PubMed |
| Novel 3,9-Disubstituted Acridines with Strong Inhibition Activity against Topoisomerase I: Synthesis, Biological Evaluation and Molecular Docking Study. | Molecules | 2023 | 36770975 | PubTator, text mining | PubMed |
| Roles of G4-DNA and G4-RNA in Class Switch Recombination and Additional Regulations in B-Lymphocytes. | Molecules | 2023 | 36770824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=15